KA
0.7
+0.13 (+22.81%)
- · NASDAQ
- Sector -
- Industry -
- Website kinetabio.com
- Employees(FY) 11
- ISIN -
Performance
-
1W
-
1M
-
3M
+2.03%
6M
-
YTD
-73.68%
1Y
Profile
Kineta, Inc. is a clinical-stage biotechnology company with a focus on developing immunotherapies that transform patients' lives. It focuses on developing potentially differentiated immunotherapies that address the challenges with current cancer therapy. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (mAb) infusion drug. KVA12123 is being evaluated in a Phase 1/2 clinical trial as a monotherapy and in combination with pembrolizumab in patients with advanced solid tumors, including non-small cell lung, ovarian, head and neck, renal cell, and colorectal cancers. It is also developing anti-CD27 agonist mAb immunotherapy, which is in preclinical development for advanced solid tumors, such as renal cell carcinoma, ovarian, and colorectal cancers. The company has collaboration and license agreements with MSD International Business GmbH, Genentech, Inc., FAIR Therapeutics B.V., and GigaGen, Inc. Kineta, Inc. was founded in 2007 and is headquartered in Seattle, Washington.
Technical Analysis of KA 2024-09-19
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-09-19 06:23
Kineta, Inc Transitioning from Nasdaq to OTC Markets(Globenewswire)
- 2024-08-19 18:33
- 2024-08-18 21:00
- 2024-08-18 21:00
- 2024-07-07 19:41
- 2024-07-07 18:30
- 2024-07-07 18:30
- 2024-06-17 19:37
- 2024-06-16 19:40
- 2024-05-28 19:39
- 2024-05-15 09:54
KA Stock Earnings: Kineta Misses EPS for Q1 2024(Investorplace)
- 2024-05-15 04:15
Kineta: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-15 04:01
- 2024-04-08 04:01
- 2024-03-21 10:54
KA Stock Earnings: Kineta Beats EPS for Q4 2023(Investorplace)
- 2024-03-21 04:02
- 2024-03-11 20:00
- 2024-02-28 20:36
- 2024-02-28 19:30
- 2024-02-21 19:30
- 2024-02-13 19:30
Kineta to Present at Upcoming Investor Conferences(Globenewswire)
- 2024-02-06 19:30
- 2024-01-16 19:30
- 2024-01-03 19:30
- 2023-12-14 19:35
- 2023-12-12 19:30
- 2023-12-12 00:02
- 2023-12-11 20:24
- 2023-11-27 19:30
- 2023-11-08 19:30
Page 1 of 3
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.